m+Medelevator.RU
← Поиск публикаций
The American journal of gastroenterology · 2026

Duodenal involvement in MUTYH-associated polyposis: findings from an international study and implications for endoscopic surveillance.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Truscott Becky, Bennett Imogen, Lacey Arron S, Aelvoet Arthur S, Sanchez Angel Alonso, Aznárez M Rosario, Backman Ann-Sofie, Bjork Jan, Capella Gabriel, Clark Susan K, Colas Chrystelle, Dardenne Antoine, Dekker Evelien, Dolwani Sunil, Drogan Christine, Dueñas Núria, Ghorbanoghli Zeinab, Romero Sara Gonzalez, Heinimann Karl, Hüneburg Robert, Kahn Caroline Ledertoug, Katona Bryson W, Kengadaran Kalaikshiga, Koeppe Erika, Kupfer Sonia S, Lindberg Lars Joachim, Mann Derek, Monaco Claudia, Mork Maureen E, Garcia Matilde Navarro, Nielsen Maartje, Parc Yann, Ricci Maria T, Saurin Jean-Christophe, Scott Anthony J, Stoffel Elena, Van de Tuin Karin, van Leerdam Monique E, Vasen Hans, Rodriguez Maribel Verdesoto, Vilar Eduardo, Vinet Olivier, Vitellaro Marco, West Hannah D, Hurley Joanna J, Latchford Andrew R, Sampson Julian R, Thomas Laura E

Аннотация

OBJECTIVES: This study aimed to better document incidence and progression of duodenal disease in MUTYH-associated polyposis (MAP).

METHODS: Incidences of duodenal cancer, and duodenal polyposis by age and genotype were assessed in individuals with genetically confirmed MAP.

RESULTS: At first endoscopy, 91/679 participants (13.4%) had duodenal adenoma(s) at a median age of 53 years (range 22 to 81 years). 439/679 participants had 1370 further endoscopies, over a median period of 6.3 years (range 1 month to 30 years). This included 365 without adenomas at first endoscopy, of whom 83 (22.7%) developed non-ampullary adenomas during follow-up at a median age of 53 years (range 29-76). Thirty-eight adenomas (5.5%) contained high-grade dysplasia (HGD), of which thirty-five had a known size and 20 (57.1%) of these were 10mm or smaller. Ampullary lesions were uncommon (31/679, 4.6%). Duodenal cancer was diagnosed in 5/679 participants (0.74%) at a median age of 65 years (range 47-83 years) and at a median of 12 months (range 9-24 months) following a surveillance endoscopy. At least four were located distally (in the third or fourth part). The cumulative incidences of duodenal adenomas and cancer at 70 years were 16.5-63.5%, depending on genotype, and 0.58%, respectively. Adenoma incidence was significantly higher in Y179C (hazard ratio 5.33 (2.94-9.67, <0.001) and E480X (4.07 (2.16-7.67), <0.001) than G396D homozygotes.

CONCLUSIONS: Future clinical guidelines for MAP should consider genotype-specific recommendations for duodenal surveillance, the importance of assessing the distal duodenum (i.e. D3, D4) and polypectomy of all detectable adenomas.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты